BIOMERICA INC Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
BIOMERICA INC (BMRA) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $0 as of 2014-02-28, per its 10-Q filed 2014-04-14.
Discontinued › Notes
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2014-04-14
- 2014-02-28: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2013-11-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2013-08-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2013-05-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $43.00K; Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) as first filed $0.00.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) as first filed |
|---|---|---|
| 2014-02-28 | $0.00 10-Q · filed 2014-04-14 | |
| 2013-11-30 | $0.00 10-Q · filed 2014-01-14 | |
| 2013-08-31 | $0.00 10-Q · filed 2013-10-15 | |
| 2013-05-31 | $43.00K 10-Q · filed 2014-04-14 | $0.00 10-K · filed 2013-08-29 |
| 2013-02-28 | $0.00 10-Q · filed 2013-04-15 | |
| 2012-11-30 | $0.00 10-Q · filed 2013-01-14 | |
| 2012-08-31 | $0.00 10-Q · filed 2012-10-12 | |
| 2012-05-31 | $43.00K 10-K · filed 2013-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |